What it's for (Indications)
- Ginkgo biloba preparations, such as Tanakan 40mg, are primarily utilized for their purported cognitive and circulatory benefits.
- The extract, particularly standardized EGb 761, is often indicated for the symptomatic treatment of age-related cognitive impairment, including memory deficits, difficulties in concentration, and depressive mood, especially when associated with cerebral circulatory insufficiency.
- It is also used in the management of intermittent claudication, a condition characterized by pain in the legs due to insufficient blood supply during exercise.
- Furthermore, some formulations are considered for conditions such as vertigo and tinnitus of vascular or involutive origin.
- It is crucial to understand that while these are traditional or studied indications, the scientific evidence supporting these uses varies, and regulatory approval can differ significantly by region.
- Patients considering Ginkgo biloba for any of these conditions should consult with a healthcare professional for an accurate diagnosis and appropriate treatment plan.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical dosage for standardized Ginkgo biloba extract (e.g., EGb 761) like that found in Tanakan 40mg preparations, generally ranges from 120 mg to 240 mg per day, administered orally in two to three divided doses. For instance, a common regimen for cognitive disorders might involve 40 mg of extract three times daily, or 80 mg twice daily. For intermittent claudication, dosages may sometimes be higher, depending on the specific product and formulation. It is imperative to follow the specific instructions provided on the product label or, more ideally, as prescribed by a healthcare professional. The onset of therapeutic effects may require several weeks of continuous administration, often ranging from 6 to 12 weeks, before a noticeable improvement is observed. Adjustments to the dosage should only be made under medical supervision, considering individual patient response, concomitant medications, and overall health status to optimize efficacy and minimize potential risks. |
Safety & Warnings
Common Side Effects
- Ginkgo biloba is generally well-tolerated, but like all pharmacologically active substances, it can cause side effects.
- Common adverse reactions are usually mild and transient, including headache, dizziness, and gastrointestinal disturbances such as nausea, diarrhea, dyspepsia, or abdominal discomfort.
- Allergic skin reactions, such as rash, itching, or hives, have also been reported in susceptible individuals.
- More serious, albeit less common, side effects primarily involve an increased risk of bleeding.
- This risk is particularly elevated in patients concurrently taking anticoagulant or antiplatelet medications.
- Isolated cases of spontaneous bleeding, including intracranial hemorrhage and epistaxis, have been reported.
- Furthermore, Ginkgo biloba contains ginkgotoxin, which at very high doses or in unpurified forms, may induce seizures, particularly in individuals with a predisposition to epilepsy.
- Any unusual or persistent side effects should be promptly reported to a healthcare professional for evaluation.
Serious Warnings
- Black Box Warning: ***SERIOUS WARNINGS: POTENTIAL FOR INCREASED BLEEDING RISK AND SEIZURES*** **INCREASED RISK OF BLEEDING:** Ginkgo biloba preparations are associated with an increased risk of bleeding, which can be severe and potentially life-threatening. This risk is significantly elevated when Ginkgo biloba is used concomitantly with anticoagulant medications (e.g., warfarin, heparin, rivaroxaban, apixaban, dabigatran) or antiplatelet agents (e.g., aspirin, clopidogrel, prasugrel, ticagrelor). The antiplatelet effects of Ginkgo biloba can be additive to these agents, leading to an exacerbated risk of hemorrhage, including spontaneous bleeding events such as intracranial hemorrhage, gastrointestinal bleeding, and epistaxis. Patients must be thoroughly counseled on the signs and symptoms of bleeding and advised to seek immediate medical attention if they experience unusual bruising, petechiae, hematoma, dark or bloody stools, red or dark urine, severe headache, dizziness, or weakness. **Ginkgo biloba must be discontinued at least 1-2 weeks prior to any surgical procedure, including dental procedures, due to the persistent risk of perioperative bleeding.** **SEIZURE RISK:** Ginkgo biloba contains ginkgotoxin, a neurotoxin that can induce seizures, particularly in individuals with a history of epilepsy or a predisposition to seizure disorders. While the levels of ginkgotoxin are typically reduced in standardized extracts, unpurified forms or excessive doses may pose a higher risk. Patients with epilepsy should avoid Ginkgo biloba entirely. Any new onset of seizures or worsening of existing seizure control should prompt immediate medical evaluation and discontinuation of Ginkgo biloba. **PREGNANCY AND LACTATION:** The use of Ginkgo biloba is not recommended during pregnancy or lactation due to insufficient safety data and the potential for adverse effects, including an increased risk of bleeding in the mother and fetus. Patients who are pregnant, planning to become pregnant, or breastfeeding should avoid this product. This section serves as a critical safety alert, emphasizing the most serious potential risks associated with Ginkgo biloba use.
- Patients should be cautioned regarding several important considerations before initiating or continuing Ginkgo biloba supplementation.
- A primary concern is the potential for increased bleeding risk, especially in individuals with pre-existing bleeding disorders or those concomitantly receiving anticoagulant medications (e.
- g.
- , warfarin, dabigatran, rivaroxaban) or antiplatelet agents (e.
- g.
- , aspirin, clopidogrel).
- Due to this risk, Ginkgo biloba should be discontinued at least 1-2 weeks prior to any scheduled surgical procedure, including dental surgery.
- Individuals with epilepsy or a history of seizures should use Ginkgo biloba with extreme caution, as components within the plant (ginkgotoxin) may lower the seizure threshold.
- It is also advisable to avoid use during pregnancy and breastfeeding due to insufficient safety data and the potential for bleeding complications.
- Patients with diabetes should monitor their blood glucose levels closely, as Ginkgo biloba may influence glucose metabolism.
- Any unusual bruising, bleeding, or other severe symptoms warrant immediate medical attention.
How it Works (Mechanism of Action)
The pharmacological effects of Ginkgo biloba extract (specifically standardized extract EGb 761) are attributed to its complex mixture of active constituents, primarily flavonoids (e.g., quercetin, kaempferol, isorhamnetin) and terpenoids (ginkgolides A, B, C, J, and bilobalide). These compounds exert multiple complementary actions. Flavonoids possess significant antioxidant properties, scavenging free radicals and reducing oxidative stress, which contributes to neuroprotection and vascular integrity. Terpenoids, particularly ginkgolides, act as platelet-activating factor (PAF) antagonists, inhibiting platelet aggregation and reducing blood viscosity, thereby improving blood flow and microcirculation, especially in cerebral and peripheral vascular beds. Additionally, Ginkgo biloba enhances vascular tone and elasticity, leading to improved cerebral perfusion. It may also modulate neurotransmitter systems, such as noradrenergic, serotonergic, and cholinergic pathways, contributing to its purported cognitive-enhancing effects. The multifaceted mechanism of action underscores its broad influence on vascular health and neuronal function.